Goupil R, Tsuyuki RT, Santesso N, Terenzi KA, Habert J, Cheng G, Gysel SC, Bruneau J, Leung AA, Campbell NRC, Schiffrin EL, Hundemer GL. Hypertension Canada guideline for the diagnosis and treatment of hypertension in primary care. CMAJ. 2025; 197:E549-64.

Hundemer GL, Agharazii M, Madore F, Piché M, Gagnon C, Bussières A, St-Jean M, Leung AA, Kline GA, Sood MM, Burger D, Ramsay T, Goupil R. Sex-specific associations of aldosterone and renin with body composition: A population-based cohort study. J Clin Endocrinol Metab. 2025; 18:110(3):801-10.

Hundemer GL, Agharazii M, Madore F, Vaidya A, Leung AA, Kline GA, Crean AM, Shaw JLV, Ramsay T, Hametner B, Wassertheurer S, Larose E, Sood MM, Hiremath S, Ruzicka M, Goupil M. Subclinical primary aldosteronism and cardiovascular health: A population-based cohort study. Circulation. 2024; 149(2):124-34.

Hundemer GL, Leung AA, Kline GA, Brown JM, Turcu AF, Vaidya A. Biomarkers to guide medical therapy in primary aldosteronism. Endocr Rev. 2024; 45(1):69-94.

Hundemer GL, Imsirovic H, Vaidya A, Yozamp N, Goupil R, Madore F, Agharazii M, Knoll G, Sood MM. Screening rates for primary aldosteronism among individuals with hypertension plus hypokalemia: A population-based retrospective cohort study. Hypertension. 2022; 79(1):178-86.

Hung A, Ahmed S, Gupta A, Davis A, Kline GA, Leung AA, Ruzicka M, Hiremath S, Hundemer GL. Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism: A systematic review and meta-analysis. J Clin Endocrinol Metab. 2021; 106(8):2423-35.

Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018; 6(1):51-9.

Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Incidence of atrial fibrillation and mineralocorticoid receptor activity in medically and surgically treated primary aldosteronism. JAMA Cardiology. 2018; 3(8):768-74.

Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Renal outcomes in medically and surgically treated primary aldosteronism. Hypertension. 2018; 72(3):658-66.

All Other Publications

Kolobaric N, Milone B, Salman M, Buh A, Biyani N, Wafy G, Fung SG, Scott M, Kiska R, Kang R, Lee K, Syed S, Gibb M, Dhaliwal S, Myran D, Maskerine C, Brown PA, Akbari A, Hundemer GL, Tanuseputro P, Fremont D, Spilg E, Sood MM. Effectiveness of wellness program interventions to improve physician wellness: A systematic review. BMC Health Serv Res. (Accepted May 20, 2025).

Glassman I, Hundemer GL. Recent advances in adrenal ablation for primary aldosteronism. Am J Hypertens. (Accepted May 16, 2025).

Wing S, Ray JG, Yau K, Jeyakumar N, Luo B, Abdullah S, Charytan D, Cherney DZI, Harel Z, Hundemer GL, Mavrakanas T, Molnar A, Odutayo A, Perl J, Weir M, Young A, Wald R. SGLT2 inhibitor initiation and risk of hyperkalemia among individuals receiving a renin-angiotensin aldosterone system inhibitor. JAMA Intern Med. (Accepted April 28, 2025).

Goupil R, Tsuyuki RT, Santesso N, Terenzi KA, Habert J, Cheng G, Gysel SC, Bruneau J, Leung AA, Campbell NRC, Schiffrin EL, Hundemer GL. Hypertension Canada guideline for the diagnosis and treatment of hypertension in primary care. Can Fam Physician. (Accepted April 2, 2025).

Goupil R, Tsuyuki RT, Santesso N, Terenzi KA, Habert J, Cheng G, Gysel SC, Bruneau J, Leung AA, Campbell NRC, Schiffrin EL, Hundemer GL. Hypertension Canada guideline for the diagnosis and treatment of hypertension in primary care. Can Pharm J. (Accepted April 2, 2025).

Leon SJ, Ferguson TW, Whitlock R, Bohm C, Komenda P, Rigatto C, Tangri N, Saad N, Ahmed S, Jablonski T, Moncrieff K, Fung R, Ahmad T, Wald R, Sidhu B, White C, Bond R, Bondaz L, Nadeau-Fredette A, Druce I, Hundemer GL, Williams L, Tennankore K, Dahl M, Levin A, Rogers A, Burgess A, Christie E, Collister D. Gender affirming hormone therapy and changes in kidney function in adults: A retrospective population-based study. Kidney Med. (Accepted April 1, 2025).

Leung AA, Padwal RS, Hundemer GL, Venos E, Campbell DJ, Holmes DT, Orton DJ, So B, Przybojewski SJ, Caughlin C, Pasieska JL, Rabi DM, Ghali WA, Kline GA. Confirmatory testing for primary aldosteronism: A study of diagnostic test accuracy. Ann Int Med. (Accepted March 21, 2025).

Olaye I, Yu C, Tuna M, Akbari A, Ramsay T, Tanuseputro P, Mucsi I, Knoll GA, Sood MM, Hundemer GL. A population-based cohort study defined estimated glomerular filtration rate decline and kidney failure among Canadian immigrants. Kidney Int. (Accepted February 25, 2025).

Helmeczi W, Hundemer GL. Targeting aldosterone to improve cardiorenal outcomes: From non-steroidal mineralocorticoid receptor antagonists to aldosterone synthase inhibitors. Submitted to Curr Opin Nephrol Hypertens. (Accepted February 18, 2025).

Hundemer GL, Akbari A, Buh A, Biyani N, Mahbub S, Salman M, Brown PA, Knoll GA, Sood MM, Hiremath S, Ruzicka M. Misclassification of hypertension status according to office blood pressure versus 24-hour ambulatory blood pressure monitoring. CJC Open. (Accepted January 8, 2025).

Harrison TG, Baragar BH, Schorr M, Verdin N, Woodlock T, Clark DA, Hundemer GL, Mustafa RA, Ryz KS, Mathew A. Identification and prioritization of Canadian Society of Nephrology clinical practice guideline topics with multidisciplinary stakeholders and people living with kidney disease. Kidney Int Rep. (Accepted November 4, 2024).

Sriperumbuduri S, Akbari A, Mangalgi S, Joshi V, Sood MM, Biyani M, McCudden C, Hundemer GL, Brown PA. Comparison of spot and 24-hour urine osmolality measurements in autosomal dominant polycystic kidney disease. Kidney Med. (Accepted October 22, 2024).

Hussain J, Imsirovic H, Talarico R, Akbari A, Ravani P, Tanuseputro P, Hundemer GL, Ramsay T, Tangri N, Knoll GA, Bugeja A, Sood MM. Population-wide eGFR percentiles by age in younger adults and clinical outcomes. Nephrol Dial Transplant. (Accepted July 4, 2024).

Yang J, Burrello J, Goi J, Reincke M, Adolf C, Asbach E, Brudgam D, Li Q, Song Y, Hu J, Satoh F, Ono Y, Libianto R, Stowasser M, Li N, Zhu Q, Hong N, Nayak D, Puar TH, Wu X, Vaidya A, Araujo-Castro M, Kocjan T, O’Toole SM, Hundemer GL, Ragnarsson O, Lacroix A, Larose S, Nakai K, Nishikawa T, Ladygina D, Turcu AF, Bass J, Fardella CE, Quinkler M, Mulatero P, Pintus G, Rossi GP, Hahner S, Amar L, Drake WM, Varsani C, Brown MJ, Deinum J, Freel EM, Kline G, Naruse M, Prejbisz A, Young WF, Williams TA, Fuller PJ. Primary aldosteronism medical treatment outcomes (PAMO): An international consensus and analysis of treatment response in an international cohort. Lancet Diabetes Endocrinol. 2025; 13(2):119-133.

Goupil R, Tsuyuki RT, Terenzi KA, Santesso N, Hundemer GL. Ushering in a new era of Hypertension Canada guidelines: A roadmap of what lies ahead. Can J Cardiol. 2025; 41(1):159-62.

Hundemer GL, Sood MM. SPRINTING to conclusions: Evaluating the long-term effects of intensive blood pressure control on kidney health. J Am Soc Nephrol. 2025; 35(12):1636-8.

Olaye I, Sood MM, Yu C, Tuna M, Akbari A, Tanuseputro P, Mucsi I, Knoll GA, Hundemer GL. Incident chronic kidney disease among Canadian immigrants: A retrospective population-based cohort study. BMJ Public Health. 2024; 2(2):e001587.

Bugeja A, Hundemer GL. Vitamin D and hypertension: An uncertain relationship at best. Am J Hypertens. 2024; 37(12):945-7.

Amooei E, Buh A, Klamrowski MM, Shorr R, McCudden CR, Green JR, Rashidi B, Sood MM, Hoar S, Akbari A, Hundemer GL, Klein R. Analytical modeling techniques for enhancing tacrolimus dosing in solid organ transplantation: A systematic review protocol. BMJ Open. 2024; 14(10):e088775.

Bugeja A, Hundemer GL, McIsaac D. Authors reply: “Adherence to guideline-recommended care of late-onset hypertension in females versus males: A population-based cohort study.” J Intern Med. 2024; 296(5):454-455.

Buh A, Scott M, Kiska R, Fung SG, Solmi M, Kang R, Salman M, Lee K, Milone B, Wafy G, Syed S, Dhaliwal S, Gibb M, Akbari A, Brown PA, Hundemer GL, Sood MM. Impact of electrolyte abnormalities and adverse outcomes in persons with eating disorders: A systematic review protocol. PLOS One. 2024; 19(8):e0308000.

Solmi M, Fabiano N, Clarke AE, Fung SG, Tanuseputro P, Knoll G, Myran DT, Bugeja A, Sood MM, Hundemer GL. Adverse outcomes and mortality in individuals with eating disorder-related electrolyte abnormalities: A population-based cohort study in Ontario, Canada. Lancet Psychiatry. 2024; 11(10):818-27.

Hundemer GL, Agharazii M. Primary aldosteronism and kidney hemodynamics: Adding another piece to the puzzle. Am J Hypertens. 2024; 37(10):748-50.

Bugeja A, Girard C, Sood MM, Kendall CE, Sweet A, Singla R, Motazedian P, Vinson AJ, Ruzicka M, Hundemer GL, Knoll G, McIsaac DI. Adherence to guideline-recommended care of late-onset hypertension in females versus males: A population-based cohort study. J Intern Med. 2024; 296(3):280-90.

Klamrowski MM, Klein R, McCudden C, Green JR, Rashidi B, White CA, Oliver MJ, Molnar A, Edwards C, Ramsay T, Akbari A, Hundemer GL. Derivation and validation of a machine learning model for the prevention of unplanned dialysis. Clin J Am Soc Nephrol. 2024; 19(9):1098-108.

Salman M, Akbari A, Hundemer GL. Kidney complications of Wilson disease and its treatments: A case report and literature review. Clin Nephrol. 2024; 102(4):248-53.

Thanabalasingam SJ, Akbari A, Sood MM, Brown PA, White CA, Moorman D, Salman M, Sriperumbuduri S, Hundemer GL. Social determinants of health and dialysis modality selection in patients with advanced chronic kidney disease. Perit Dial Int. 2024; 44(4):245-53.

Akbari A, El Wadia H, Knoll GA, White CA, Sood MM, Massicotte-Azarniouch D, McCudden C, Deschenes MJ, Salman M, Ramsay T, Hundemer GL. Comparison of eGFR equations to guide dosing of medications for kidney transplant recipients. Transplantation. 2024; 108(11):2270-7.

Bugeja A, Hundemer GL, Hiremath S. Resistant hypertension. CMAJ. 2024; 196(26):E905.

Toye C, Sood MM, Mallick R, Akbari A, Bieber B, Karaboyas A, Guedes M, Hundemer GL. Comparison of β-blocker agents and mortality in maintenance hemodialysis patients: An international cohort study. Clin Kidney J. 2024; 17(5):sfae087.

Bugeja A, Girard C, Sood MM, Kendall CE, Sweet A, Singla R, Motazedian P, Ruzicka M, Hundemer GL, Knoll G, McIsaac DI. Sex-related disparities in cardiovascular outcomes among older adults with late-onset hypertension. Hypertension. 2024; 81(7):1583-91.

Thanabalasingam SJ, Iliescu EA, Norman PA, Day AG, Akbari A, Hundemer GL, White CA. Kidney Failure Risk Equation thresholds for multidisciplinary kidney care referrals: A validation study. Kidney Med. 2024; 6(4):100805.

Buh A, Kang R, Kiska R, Fung SG, Solmi M, Scott M, Salman M, Lee K, Milone B, Wafy G, Syed S, Dhaliwal S, Gibb M, Akbari A, Brown PA, Hundemer GL, Sood MM. Effect and outcome of equity, diversity, and inclusion programs in healthcare institutions: A systematic review protocol. BMJ Open. 2024; 14(4):e085007.

Hundemer GL, Sood MM, Akbari A. Beyond creatinine: Is cystatin C’s emergence the new global standard for eGFR evaluation? Kidney Med. 2024; 6(4):100806.

Samnani S, Cenzer I, Kline GA, Lee SJ, Hundemer GL, McClurg C, Pasieka JL, Boscardin WJ, Ronksley PE, Leung AA. Time to benefit of surgery vs. targeted medical therapy for patients with primary aldosteronism: A meta-analysis. J Clin Endocrinol Metab. 2024; 109(3):e1280-9.

Hundemer GL, Akbari A, Sood MM. Has the time come for age-adapted GFR criteria to define CKD: How soon is now? Curr Opin Nephrol Hypertens. 2024; 33(3):318-24.

Hundemer GL. Intraprocedural cortisol testing during adrenal vein sampling for primary aldosteronism: Weighing the benefits and limitations. Am J Hypertens. 2024; 37(2):104-6.

Sriperumbuduri S, Welling P, Ruzicka M, Hundemer GL, Hiremath S. Potassium and hypertension: A state-of-the-art review. Am J Hypertens. 2024; 37(2):91-100.

Hussain J, Grubic N, Akbari A, Canney M, Elliott MJ, Ravani P, Tanuseputro P, Clark EG, Hundemer GL, Ramsay T, Tangri N, Knoll GA, Sood MM. Associations between modest reductions in kidney function and adverse outcomes in young adults: Retrospective, population based cohort study. BMJ. 2023; 381:e075062.

Baragar BH, Schorr M, Verdin N, Woodlock T, Clark DA, Hundemer GL, Mathew A, Mustafa RA, Ryz KS, Harrison T. Identification and prioritization of Canadian Society of Nephrology clinical practice guideline topics with multidisciplinary stakeholders and people living with kidney disease: A clinical research protocol. Can J Kidney Health Dis. 2023 Nov 24:10:20543581231207142.

Klamrowski MM, Klein R, McCudden C, Green JR, Ramsay T, Rashidi B, White CA, Oliver MJ, Akbari A, Hundemer GL. Short timeframe prediction of kidney failure among patients with advanced chronic kidney disease. Clin Chem. 2023; 69(10):1163-73.

Hussain J, Imsirovic H, Canney M, Clark EG, Elliott MJ, Ravani P, Tanuseputro P, Akbari A, Hundemer GL, Ramsay T, Tangri N, Knoll GA, Sood MM. Impaired renal function and major cardiovascular events in young adults. J Am Coll Cardiol. 2023; 82(13):1316-27.

Cohen DL, Wachtel H, Vaidya A, Hundemer GL, Tezuka Y, Davio A, Turcu AF, Cohen JB. Primary aldosteronism in chronic kidney disease: Blood pressure control and kidney and cardiovascular outcomes after surgical versus medical management. Hypertension. 2023; 80(10):2187-95.

Noor ST, Bota SE, Clarke AE, Petrcich W, Kelly D, Knoll G, Hundemer GL, Canney M, Tanuseputro P, Sood MM. Stroke subtype among individuals with chronic kidney disease. Can J Kidney Health Dis. 2023 Oct 14; 10:20543581231203046.

Hundemer GL, Ravani P, Sood MM, Zimmerman D, Molnar AO, Moorman D, Oliver MJ, White C, Hiremath S, Akbari A. Social determinants of health and the transition from advanced chronic kidney disease to kidney failure. Nephrol Dial Transplant. 2023; 38(7):1682-90.

Hundemer GL, Imsirovic H, Visram A, McCurdy A, Knoll G, Biyani M, Canney M, Massicotte-Azarniouch D, Tanuseputro P, McCudden C, Sood MM, Akbari A. The association between the urine protein-to-albumin gap and the diagnosis of multiple myeloma: A population-based retrospective cohort study. Am J Kidney Dis. 2023; 81(6):732-4.

Bourque G, Ilin JV, Ruzicka M, Hundemer GL, Shorr R, Hiremath S. Nonadherence is common in patients with apparent resistant hypertension: A systematic review and meta-analysis. Am J Hypertens. 2023; 36(7):394-403.

Hundemer GL, Imsirovic H, Kendzerska T, Vaidya A, Leung AA, Kline GA, Goupil R, Madore F, Agharazii M, Knoll G, Sood MM. Screening for primary aldosteronism among hypertensive adults with obstructive sleep apnea: A retrospective population-based study. Am J Hypertens. 2023; 36(7):363-71.

Madken M, Mallick R, Rhodes E, Mahdavi R, Eddeen AB, Hundemer GL, Kelly DM, Pecoits-Filho R, Robinson B, Bieber B, Molnar AO, Knoll G, Sood MM. Development and validation of a predictive risk algorithm for bleeding in individuals on long-term hemodialysis: An international prospective cohort study (BLEED-HD). Can J Kidney Health Dis. 2023 Jun 22; 10:20543581231169610.

Hiremath S, Hundemer GL. Evidence and uncertainties surrounding renin-guided medical therapy for primary aldosteronism. Am J Hypertens. 2023; 36(8):428-30.

Goupil R, Nadeau-Fredette A, Prasad B, Hundemer GL, Suri RS, Beaubien-Souligny W, Agharazii M. Central blood pressure targeting: A pragmatic randomized trial in advanced chronic kidney disease (CENTRAL-CKD): A clinical research protocol. Can J Kidney Health Dis. 2023 May 6; 10:20543581231172407.

Farfan Ruiz AC, Malick R, Rhodes E, Canney M, Clark EG, Hundemer GL, Karaboyas A, Robinson B, Pecoits R, Sood MM. Adverse gastrointestinal events with sodium polystyrene sulfonate use in patients on maintenance hemodialysis: An international cohort study. Can J Kidney Health Dis. 2023 Jun 21; 10:20543581231172405.

Massicotte-Azarniouch D, Canney M, Sood MM, Hundemer GL. Managing hyperkalemia in the modern era: A case-based approach. Kidney Int Rep. 2023; 8(7):1290-300.

Wang T, Grubic N, Carrier M, Canney M, Delluc A, Hundemer GL, Knoll G, Lazo-Langner A, Massicotte-Azarniouch, Tanuseputro P, Sood MM. Risk of venous thromboembolism or hemorrhage among individuals with chronic kidney disease on prophylactic anticoagulant after hip or knee arthroplasty. Am J Hematol. 2023; 98(9):1374-82.

Dubrofsky L, Hundemer GL. Five things to know about: Screening for primary aldosteronism in primary care. CMAJ. 2023; 195(11):E410.

Hundemer GL, Sood MM, Canney M. Recent updates in kidney risk prediction modeling: Novel approaches and earlier outcomes. Curr Opin Nephrol Hypertens. 2023; 18(10):257-62.

Noel A, Eddeen AB, Manuel DG, Rhodes E, Tangri N, Hundemer GL, Tanuseputro P, Knoll GA, Mallick R, Sood MM. A health survey-based prediction equation for incident CKD. Clin J Am Soc Nephrol. 2023; 18(1):28-35.

Hundemer GL, Clarke A, Akbari A, Bugeja A, Massicotte-Azarniouch D, Knoll G, Myran DT, Tanuseputro P, Sood MM. Analysis of electrolyte abnormalities in adolescents and adults and subsequent diagnosis of an eating disorder. JAMA Netw Open. 2022; 5(11):e2240809.

Hundemer GL. Causes, evaluation, and treatment of secondary and resistant hypertension. Nephrol Self Assess Program. 2022; 21(4):296-310.

Vaidya A, Hundemer GL, Nanba K, Parksook W, Brown JM. Primary aldosteronism: State-of-the-art review. Am J Hypertens. 2022; 35(12):967-88.

Hundemer GL, White CW, Norman PA, Knoll GA, Tangri N, Sood MM, Hiremath S, Burns KD, McCudden C, Akbari A. Performance of the 2021 race-free CKD-EPI creatinine- and cystatin C-based eGFR equations among kidney transplant recipients. Am J Kidney Dis. 2022; 80(4):462-72.

Leung AA, Symonds CJ, Hundemer GL, Ronksley PE, Lorenzetti DL, Pasieka JL, Harvey A, Kline GA. Performance of confirmatory tests for diagnosing primary aldosteronism: A systematic review and meta-analysis. Hypertension. 2022; 79(8):1835-44.

Ahmed S, Massicotte-Azarniouch D, Canney M, Booth C, Blanco P, Hundemer GL. The value of repeat kidney biopsy during an atypical course of membranous nephropathy. BMC Nephrology. 2022; 23(1):240. June 23, 2022.

Ahmed S, Hundemer GL. Benefits of surgical over medical treatment for unilateral primary aldosteronism. Front Endocrinol. 2022;13:861581.

Parksook WW, Yozamp N, Hundemer GL, Moussa M, Underhill J, Fudim T, Sacks B, Vaidya A. Morphologically normal-appearing adrenal glands as a prevalent source of aldosterone production in primary aldosteronism. Am J Hypertens. 2022; 35(6):561-71.

Thanabalasingam SJ, Iliescu EA, Norman PA, Day AG, Akbari A, Hundemer GL, White CA. Independent external validation and comparison of death and kidney replacement therapy prediction models in advanced CKD. Kidney Med. 2022; 4(4):100440.

Canney M, Sood MM, Hundemer GL. Contemporary risk prediction in CKD: When less is more. Curr Opin Nephrol Hypertens. 2022; 31(3):297-302.

Hill K, Sucha E, Rhodes E, Bota S, Hundemer GL, Clark E, Canney M, Harel Z, Wang T, Carrier M, Wijeysundera H, Knoll G, Sood MM. Amiodarone, verapamil or diltiazem use with direct oral anticoagulants and the risk of hemorrhage in older adults. CJC Open. 2022; 4(3):315-23.

Sam D, Kline GA, So B, Hundemer GL, Pasieka J, Harvey A, Chin A, Przybojewski S, Leung AA. External validation of clinical prediction models in unilateral primary aldosteronism. Am J Hypertens. 2022; 35(4):365-73.

Hundemer GL, Sood MM, Ramsay T, Akbari A. Urinary potassium excretion and progression from advanced CKD to kidney failure. Can J Kidney Health Dis. 2022 Mar 19; 9:20543581221084501.

Hundemer GL, Sood MM. Growing understanding of the clinical and serological effects of COVID-19 vaccines in patients undergoing long-term dialysis. Clin J Am Soc Nephrol. 2022; 17(3):335-7.

Massicotte-Azarniouch D, Petrcich W, Walsh M, Canney M, Hundemer GL, Milman N, Hladunewich MA, Fairhead T, Sood MM. Association of ANCA-associated vasculitis and cardiovascular events: A population-based cohort study. Clin Kidney J. 2021; 15(4):681-92.

Clark EG, McIntyre L, Watpool I, Kong JWY, Ramsay T, Sabri E, Canney M, Hundemer GL, Brown PA, Sood MM, Hiremath S. Intravenous albumin for the prevention of hemodynamic instability during sustained low-efficiency dialysis: A randomized controlled feasibility trial (The SAFER-SLED Study). Ann Intensive Care. 2021; 11(1):174.

Hundemer GL, Sood MM. Hyperkalemia with RAAS inhibition: Mechanism, clinical significance, and management. Pharmacol Res. 2021 Oct; 172:105835.

Hundemer GL, Tangri N, Sood MM, Clark EG, Canney M, Edwards C, White CA, Oliver MJ, Ramsay T, Akbari A. The effect of age on performance of the Kidney Failure Risk Equation in advanced CKD. Kidney Int Rep. 2021; 6(12):2993-3001.

Canney M, Sood MM, Hundemer GL. Reducing the risk of atrial fibrillation in ESKD: Is the devil in the dialysis? Nephrol Dial Transplant. 2021; 36(11):1963-4.

Hundemer GL, Kline GA, Leung AA. Response letter to the editor from Zhu et al.: “Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism: A systematic review and meta-analysis.” J Clin Endocrinol Metab. 2021; 106(10):e4300-1.

Hundemer GL*, Edwards C*, Petrcich W, Canney M, Knoll G, Burns K, Bugeja A, Sood MM. Comparison of clinical outcomes and safety associated with chlorthalidone vs. hydrochlorothiazide in older adults with varying levels of kidney function. JAMA Netw Open. 2021; 4(9):e2123365. *Contributed Equally as Co-First Authors.

Akbari A, Kunkel E, Bota S, Harel Z, Le Gal G, Cox C, Hundemer GL, Canney M, Clark E, Massicotte-Azarniouch D, Eddeen AB, Knoll G, Sood MM. Proteinuria and venous thromboembolism in pregnancy: A population-based cohort study. Clin Kidney J. 2021; 14(9):2101-7.

Sriperumbuduri S, McArthur E, Hundemer GL, Canney M, Tangri N, Leon SJ, Bota S, Bugeja A, Akbari A, Knoll G, Sood MM. Initial and recurrent hyperkalemia events in patients with CKD in older adults: A population-based cohort study. Can J Kidney Health Dis. 2021 May 27; 8:20543581211017408.

Yozamp N, Hundemer GL, Moussa M, Underhill J, Fudim T, Sacks B, Vaidya A. Adrenocorticotropic hormone-stimulated adrenal venous sampling underestimates surgically curable primary aldosteronism: A retrospective cohort study and review of contemporary studies. Hypertension. 2021; 78(1):94-103.

Hundemer GL, Talarico R, Tangri N, Leon SJ, Knoll GA, Sood MM. Ambulatory treatments for RAAS inhibitor-related hyperkalemia and the 1-year risk of recurrence. Clin J Am Soc Nephrol. 2021; 16(3):365-73.

Hundemer GL, Kline GA, Leung AA. How common is primary aldosteronism? Curr Opin Nephrol Hypertens. 2021; 30(3):353-60.

Ahmed S, Blanco P, MacDonald DA, Hundemer GL. The case ¦ Nephrotic syndrome in a patient with chronic lymphocytic leukemia. Kidney Int. 2021; 99(3):777-8.

Yozamp N, Hundemer GL, Moussa M, Underhill J, Fudim T, Sacks B, Vaidya A. Variability of aldosterone measurements during adrenal venous sampling for primary aldosteronism. Am J Hypertens. 2021; 34(1):34-45.

Yozamp N, Hundemer GL, Moussa M, Underhill J, Fudim T, Sacks B, Vaidya A. Intraindividual variability of aldosterone concentrations in primary aldosteronism: Implications for case detection. Hypertension. 2021; 77(3):891-9.

Hundemer GL, Knoll GA, Petrcich W, Hiremath S, Ruzicka M, Burns KD, Edwards C, Bugeja A, Rhodes E, Sood MM. Kidney, cardiac, and safety outcomes associated with alpha blockers in patients with CKD: A population-based cohort study. Am J Kidney Dis. 2021; 77(2):178-89.

Hundemer GL, Srivastava A, Jacob KA, Krishnasamudram N, Ahmed S, Boerger E, Sharma S, Pokharel KK, Hirji SA, Pelletier MP, Safa K, Kulvichit W, Kellum JA, Riella LV, Leaf DE. Acute kidney injury in renal transplant recipients undergoing cardiac surgery. Nephrol Dial Transplant. 2021; 36(1):185-96.

Hundemer GL, Sood MM, Canney M. β-blockers in hemodialysis: Simple questions, complicated answers. Clin Kidney J. 2020; 14(3):731-4.

Clark EG, Hiremath S, McIntyre L, Wald R, Hundemer GL, Joannidis M. Haemoperfusion should only be used for COVID-19 in the context of randomized trials. Nat Rev Nephrol. 2020; 16(12):697-9.

Hundemer GL, Vaidya A. MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism. Eur J Endocrinol. 2020; 183(6):R183-94.

Martin CE, Clotet-Freixas S, Farragher JF, Hundemer GL. A narrative review of uremic pruritus in 2020: Have we just scratched the surface? Can J Kidney Health Dis. 2020 Oct 15; 7:2054358120954024.

Hundemer GL, Tangri N, Sood MM, Bugeja A, Brown PA, Clark EG, Biyani M, White CA, Akbari A. Performance of the Kidney Failure Risk Equation by kidney disease etiology in severe chronic kidney disease. Clin J Am Soc Nephrol. 2020; 15(10):1424-32.

Rabi DM, McBrienK, Sapir-Pichhadze R, Nakhla M, Ahmed SB, Dumanski S, Butalia S, Leung AA, Harris KC, Cloutier L, Zarnke KB, Ruzicka M, Hiremath S, Feldman RD, Tobe SW, Campbell TS, Bacon SL, Nerenberg KA, Dresser GK, Fournier A, Burgess E, Lindsay P, Rabkin SW, Prebtani APH, Grover S, Honos G, Alfonsi JE, Arcand J, Audibert F, Benoit G, Bittman J, Bolli P, Cote A, Dionne J, Don-Wauchope A, Edwards C, Firoz T, Gabor JY, Gilbert RE, Gregoire JC, Gryn SE, Gupta M, Hannah-Shmouni F, Hegele RA, Herman RJ, Hill MD, Howlett JG, Hundemer GL, Jones C, Kaczorowski J, Khan N, Kuyper LM, Lamarre-Cliché M, Lavoie KL, Leiter LA, Lewanczuk R, Logan AG, Magee LA, Mangat BK, McFarlane PA, McLean D, Michaud A, Milot A, Moe GW, Penner SB, Pipe A, Poppe AY, Rey E, Roerecke M, Schiffrin EL, Selby P, Sharma M, Shoamanesh A, Sivapalan P, Townsend RR, Tran KC, Trudeau L, Tsuyuki RT, Vallee M, Woo V, Bell AD, Daskalopoulou SS. Hypertension Canada’s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children. Can J Cardiol. 2020; 36(5):596-624.

Hill K, Sucha E, Rhodes E, Carrier M, Garg AX, Harel Z, Hundemer GL, Clark EG, Knoll G, Sood MM. Risk of hospitalization with hemorrhage among older adults taking clarithromycin vs. azithromycin and direct oral anticoagulants. JAMA Intern Med. 2020; 180(8):1052-60.

Hundemer GL, Vaidya A. Primary aldosteronism diagnosis and management: A clinical approach. Endocrinol Metab Clin North Am. 2019; 48(4):681-700.

Jegatheswaran J, Hundemer GL, Massicotte-Azarniouch D, Sood MM. Anticoagulation in patients with advanced chronic kidney disease: Walking the fine line between benefit and harm. Can J Cardiol. 2019; 35(9):1241-55.

Hundemer GL, Sood MM. Is it time to recalibrate cardiac prediction tools to accommodate CKD? Can J Cardiol. 2019; 35(9):1082-4.

Hundemer GL. Primary aldosteronism: Cardiovascular outcomes pre- and post-treatment. Curr Cardiol Rep. 2019; 21(9):93.

Hiremath S, Ruzicka M, Petrcich W, McCallum M, Hundemer GL, Tanuseputro P, Manuel D, Burns K, Edwards C, Bugeja A, Magner P, McCormick B, Garg AX, Rhodes E, Sood MM. Alpha-blocker use and the risk of hypotension and hypotension-related clinical events in women of advanced age. Hypertension. 2019; 74(3):645-51.

Hundemer GL, Sood MM. Predialysis care and cardiovascular outcomes: Why the lead up to dialysis matters. Kidney Int Rep. 2019; 4(5):635-7.

Sise, ME, Backman E, Ortiz G, Hundemer GL, Ufere N, Chute DF, Brancale J, Xu D, Wisocky J, Lin MV, Kim AY, Thadhani R, Chung RT. Effect of sofosbuvir-based hepatitis C virus therapy on kidney function in patients with CKD. Clin J Am Soc Nephrol. 2017; 12(10):1615-23.

Hundemer GL, Baudrand R, Brown JM, Curhan G, Williams GH, Vaidya A. Renin phenotypes characterize vascular disease, autonomous aldosteronism, and mineralocorticoid receptor activity. J Clin Endocrinol Metab. 2017; 102(6):1835-43.

Hundemer GL, Fenves AZ. Acquired 5-oxoproline acidemia successfully treated with N-acetylcysteine. Proc (Bayl Univ Med Cent). 2017; 30(2):169-70.

Hoda RS, Sanyal S, Abraham JL, Everett JM, Hundemer GL, Yee E, Lauwers GY, Tolkoff-Rubin N, Misdraji J. Lanthanum deposition from oral lanthanum carbonate in the upper gastrointestinal tract. Histopathology. 2017; 70(7):1072-8.

Baudrand R, Guarda FJ, Fardella C, Hundemer GL, Brown J, Williams G, Vaidya A. Continuum of renin-independent aldosteronism in normotension. Hypertension. 2017; 69(5):950-6.

Hundemer GL, Rosales IA, Chen YB, Colvin RB, Tolkoff-Rubin NE. Hydroxyurea for treatment of nephrotic syndrome associated with polycythemia vera. Am J Kidney Dis. 2016; 68(3):465-8.

Hundemer GL, Fenves AZ, Phillips KM, Emmett M. Sodium thiosulfate and the anion gap in patients treated by hemodialysis. Am J Kidney Dis. 2016; 68(3):499-500.

Hundemer GL, Sise ME, Wisocky J, Ufere N, Friedman LS, Corey KE, Chung RT. Use of Sofosbuvir-based direct-acting antiviral therapy for hepatitis C viral infection in patients with severe renal insufficiency. Infectious Diseases. 2015; 47(12):924-9.

Allegretti AS, Hundemer GL, Chorghade R, Cosgrove K, Bajwa E, Bhan I. Perspectives of continuous renal replacement therapy in the intensive care unit: A paired survey study of patient, physician, and nurse views. BMC Nephrol. 2015 Jul 14; 16:105.

Hundemer GL, Kumar V, Vaduganathan M. Large-volume barium aspiration. Proc (Bayl Univ Med Cent). 2015; 28(2):183-4.

Hundemer GL, Fenves AZ. Unmasking immune reconstitution inflammatory syndrome: Nontuberculous mycobacterial scrofula. Am J Med. 2014; 127(7):e5-e6.

Reinert RB, Brissova M, Shostak A, Pan FC, Poffenberger G, Cai Q, Hundemer GL, Kantz J, Thompson CS, Dai C, McGuinness OP, Powers AC. Vascular endothelial growth factor-A and islet vascularization are necessary in developing, but not adult, pancreatic islets. Diabetes. 2013; 62(12):4154-64.

Hundemer GL, Jersey SL, Stuart RP, Butler WP, Pilmanis AA. Altitude decompression sickness incidence among U-2 pilots: 1994-2010. Aviat Space Environ Med. 2012; 83(10):968-74.

Jersey SL, Hundemer GL, Stuart RP, West KN, Michaelson RS, Pilmanis AA. Neurological altitude decompression sickness among U-2 pilots: 2002-2009. Aviat Space Environ Med. 2011; 82(7):673-82.

Von Thesling GH, Coffman CB, Hundemer GL, Stuart RP. In-flight urine collection device: Efficacy, maintenance, and complications in U-2 pilots. Aviat Space Environ Med. 2011; 82(2):116-22.

Chan RC, Hundemer GL, Tatsas A, Cookson MS. Urothelial carcinoma of the bladder metastatic to bone marrow presenting as isolated thrombocytopenia. ScientificWorldJournal. 2007; 7:1000-3.